<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Swoboda RK</submitter><funding>NCI NIH HHS</funding><pagination>14009</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4782943</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>1</volume><pubmed_abstract>Noncoding regions of the genome play an important role in tumorigenesis of cancer. Using expression cloning, we have identified a cytotoxic T lymphocyte (CTL)-defined antigen that recognizes a protein sequence derived from an open reading frame transcribed from the reverse strand in the 3' untranslated region of tRNA isopentenyltransferase 1 (TRIT1). A peptide derived from this open reading frame (ORF) sequence and predicted to bind to HLA-B57, sensitized HLA-B57(+) tumor cells to lysis by CTL793. The peptide also induced a CTL response in peripheral blood mononuclear cells (PBMC) of patient 793 and in two other melanoma patients. The CTL lysed peptide-pulsed HLA-B57(+) target cells and melanoma cells with endogenous antigen expression. The recognition of this antigen is not limited to HLA</pubmed_abstract><journal>Molecular therapy oncolytics</journal><pubmed_title>Antimelanoma CTL recognizes peptides derived from an ORF transcribed from the antisense strand of the 3' untranslated region of TRIT1.</pubmed_title><pmcid>PMC4782943</pmcid><funding_grant_id>P30 CA010815</funding_grant_id><funding_grant_id>P01 CA114046</funding_grant_id><funding_grant_id>P01 CA025874</funding_grant_id><pubmed_authors>Herlyn M</pubmed_authors><pubmed_authors>Somasundaram R</pubmed_authors><pubmed_authors>Robbins P</pubmed_authors><pubmed_authors>Swoboda RK</pubmed_authors><pubmed_authors>Marincola FM</pubmed_authors><pubmed_authors>Caputo-Gross L</pubmed_authors><pubmed_authors>Herlyn D</pubmed_authors></additional><is_claimable>false</is_claimable><name>Antimelanoma CTL recognizes peptides derived from an ORF transcribed from the antisense strand of the 3' untranslated region of TRIT1.</name><description>Noncoding regions of the genome play an important role in tumorigenesis of cancer. Using expression cloning, we have identified a cytotoxic T lymphocyte (CTL)-defined antigen that recognizes a protein sequence derived from an open reading frame transcribed from the reverse strand in the 3' untranslated region of tRNA isopentenyltransferase 1 (TRIT1). A peptide derived from this open reading frame (ORF) sequence and predicted to bind to HLA-B57, sensitized HLA-B57(+) tumor cells to lysis by CTL793. The peptide also induced a CTL response in peripheral blood mononuclear cells (PBMC) of patient 793 and in two other melanoma patients. The CTL lysed peptide-pulsed HLA-B57(+) target cells and melanoma cells with endogenous antigen expression. The recognition of this antigen is not limited to HLA</description><dates><release>2015-01-01T00:00:00Z</release><publication>2015</publication><modification>2025-04-04T14:23:32.872Z</modification><creation>2019-03-27T02:10:40Z</creation></dates><accession>S-EPMC4782943</accession><cross_references><pubmed>27119099</pubmed><doi>10.1038/mto.2014.9</doi></cross_references></HashMap>